Literature DB >> 1602543

Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes.

A Marcuzzi1, J Weinberger, O K Weinberger.   

Abstract

One of the unexplained aspects of the progression of AIDS is that immunological abnormalities are detectable before CD4+ T-helper cell depletion occurs (A.R. Gruters, F.G. Terpstra, R. De Jong, C.J.M. Van Noesel, R.A.W. Van Lier, and F. Miedema, Eur. J. Immunol. 20:1039-1044, 1990; F. Miedema, A.J. Chantal-Petit, F.G. Terpstra, J.K.M.E. Schattenkerk, F. de Wolf, B.J.M. Al, M. Roos, J.M.A. Lang, S.A. Danner, J. Goudsmit, and P.T.A. Schellekens, J. Clin. Invest. 82:1908-1914, 1988; G.M. Shearer, D.C. Bernstein, K.S. Tung, C.S. Via, R. Redfield, S.Z. Salahuddin, and R.C. Gallo, J. Immunol. 137:2514-2521, 1986). In this report, we describe a mechanism by which human immunodeficiency virus type 1 (HIV-1)-infected cells can influence neighboring HIV-1-infected T lymphocytes and uninfected T cells as well. We have examined the interaction of T-cell and macrophage cell lines that are transfected with HIV-1 DNA by using cocultured lymphocytes. The HIV-1 constructs we used lack a functional pol gene and therefore do not produce infectious virus. Cocultivation results in the transcellular activation of the HIV long terminal repeat in the cocultured T cells. This transcellular activation is evident in as little as 3 h of cocultivation, at ratios of HIV-expressing cells to target cells as low as 1:1,000, and is dependent on the Tat-responsive element. The demonstration that a small number of HIV-expressing cells can affect a large number of uninfected bystander cells in a short period of time suggests a mechanism by which global immune dysfunction can precede the high prevalence of infected cells.

Entities:  

Mesh:

Year:  1992        PMID: 1602543      PMCID: PMC241226     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.

Authors:  D L Mann; F Lasane; M Popovic; L O Arthur; W G Robey; W A Blattner; M J Newman
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

4.  Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.

Authors:  D C Diamond; B P Sleckman; T Gregory; L A Lasky; J L Greenstein; S J Burakoff
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  Lymphocyte activation by HIV-1 envelope glycoprotein.

Authors:  H Kornfeld; W W Cruikshank; S W Pyle; J S Berman; D M Center
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

6.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

7.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.

Authors:  J Sodroski; W C Goh; C Rosen; K Campbell; W A Haseltine
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

8.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

Authors:  M A Muesing; D H Smith; D J Capon
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

9.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.

Authors:  J D Lifson; G R Reyes; M S McGrath; B S Stein; E G Engleman
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

10.  Endocytosis and targeting of exogenous HIV-1 Tat protein.

Authors:  D A Mann; A D Frankel
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  14 in total

1.  Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.

Authors:  S Mitola; R Soldi; I Zanon; L Barra; M I Gutierrez; B Berkhout; M Giacca; F Bussolino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression.

Authors:  S Rasty; P Thatikunta; J Gordon; K Khalili; S Amini; J C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.

Authors:  Fabienne Rayne; Solène Debaisieux; Hocine Yezid; Yea-Lih Lin; Clément Mettling; Karidia Konate; Nathalie Chazal; Stefan T Arold; Martine Pugnière; Françoise Sanchez; Anne Bonhoure; Laurence Briant; Erwann Loret; Christian Roy; Bruno Beaumelle
Journal:  EMBO J       Date:  2010-03-11       Impact factor: 11.598

4.  Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in T lymphocytes requires CD4-gp120 binding.

Authors:  A Marcuzzi; I Lowy; O K Weinberger
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/β-catenin signaling in astrocytes: relevance to HIV neuropathogenesis.

Authors:  Lisa J Henderson; Amit Sharma; Maria Chiara G Monaco; Eugene O Major; Lena Al-Harthi
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

6.  HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

Authors:  Brian Giunta; Yuyan Zhou; Huayan Hou; Elona Rrapo; Francisco Fernandez; Jun Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells.

Authors:  S C Flores; J C Marecki; K P Harper; S K Bose; S K Nelson; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

Authors:  Teresa G D'Aversa; Karl O A Yu; Joan W Berman
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

9.  Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.

Authors:  D N Levy; Y Refaeli; D B Weiner
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

Review 10.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.